News
Roivant Sciences: Why Its ‘Vant’ Biotech Model Is A Buy (NASDAQ:ROIV)
Roivant Sciences Ltd. (NASDAQ:ROIV) is a pioneering biotech focused on inflammation and immunology that operates with an innovative business model…
Coca-Cola: Why A Bullish Thesis Isn’t Hard To Understand (NYSE:KO)
I upgraded my thesis on The Coca-Cola Company (NYSE:KO) stock in mid-September 2023, assessing it was reasonable to be more…
Hecla Mining: A Highly Leveraged Silver Miner. (NYSE:HL)
Introduction Most investors don’t see what is about to happen. The US economy and US government are over-leveraged. They have…
Eagle Point Income: The 2026 Term Preferred Shares Offer A 8% YTM (NYSE:EIC)
Introduction Eagle Point Income (NYSE:EIC) is an investment company focusing on the BB tranches of CLO debt. And just like…
Moderna’s Flu/COVID Vaccine Prospects Are Undervalued By The Market (NASDAQ:MRNA)
At a Glance Delving into Moderna's (NASDAQ:MRNA) trajectory, my earlier analysis shed light on its eclectic project range. This spectrum…
Deutsche Bank: Not Much Upside Ahead (NYSE:DB)
Deutsche Bank (NYSE:DB) has improved its performance in recent quarter supported by rising rates, a trend that is expected to…
Walgreens: When Slashing The Dividend Is Sign To Be Bullish (NASDAQ:WBA)
A lot of people like to think of the world in terms of black and white. Something is either good…
Medical Properties Stock: Time To Be Greedy And Load Up (NYSE:MPW)
My Thesis Medical Properties Trust (NYSE:MPW) stock fell 29% on January 5, 2024, and has fallen more than 70% overall…